Inventor profile of:

Thomas Grunwald

City:

Hamburg

Country:

Germany

Published Applications:

20

Last publication date:

2022-09-01

Top Assignees for applications by Thomas Grunwald

The entities that hold a legal rights for patent applications filed by inventor Grunwald Thomas:

Recent patent applications by Grunwald Thomas

Thomas Grunwald from Hamburg, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2022-09-01
US20220273791A1
Human necessities

SELECTIVE LOCAL INHIBITION OF TNFR1-MEDIATED FUNCTIONS AT THE SITE OF ANTIGEN/ALLERGEN PRESENTATION

#2 | 2019-09-19
US20190282692A1
Human necessities

SELECTIVE LOCAL INHIBITION OF TNFR1-MEDIATED FUNCTIONS AT THE SITE OF ANTIGEN/ALLERGEN PRESENTATION

#3 | 2018-05-03
US20180117143A1
Human necessities

PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ALLERGIC REACTIONS

#4 | 2018-03-29
US20180085452A1
Human necessities

MATRIX-EMBEDDED TOLERANCE-PROMOTING ADJUVANTS FOR SUBCUTANEOUS IMMUNOTHERAPY

#5 | 2017-03-16
US20170072048A1
Human necessities

SELECTIVE LOCAL INHIBITION OF TNFR1-MEDIATED FUNCTIONS AT THE SITE OF ANTIGEN/ALLERGEN PRESENTATION

#6 | 2016-11-24
US20160338955A1
Human necessities

ANTIGEN-SPECIFIC IMMUNOTHERAPY USING TOLERIZING LIPOSOMES

#7 | 2016-09-22
US20160271257A1
Human necessities

Low Molecular Weight Immune-Modulators As Adjuvants for Specific Immunotherapy

#8 | 2015-10-08
US20150283231A1
Human necessities

Induction of antigen-specific tolerance by peripheral phagocytosis

#9 | 2014-11-13
US20140335162A1
Human necessities

PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ALLERGIC REACTIONS

#10 | 2014-06-26
US20140178474A1
Human necessities

SELECTIVE LOCAL INHIBITION OF TNFR1-MEDIATED FUNCTIONS AT THE SITE OF ANTIGEN/ALLERGEN PRESENTATION

#11 | 2014-06-12
US20140163200A1
Chemistry; metallurgy

Method for determining an unknown PNA sequence and uses thereof

#12 | 2013-12-19
US20130337045A1
Human necessities

Controlled activation of complement components for use as endogenous adjuvant

#13 | 2013-12-19
US20130337044A1
Human necessities

MODULATION OF EFFECTOR T CELL RESPONSES BY LOCAL DEPLETION OF COMPLEMENT COMPONENT C3

#14 | 2012-01-12
US20120009187A1
Human necessities

Cloning and recombinant productions of venom protease and methods of use thereof

#15 | 2011-03-01
US11581874
-

Chimera of human IgE receptor α-chain and avian constant immuno-globulin domains for the determination of serum IgE

#16 | 2010-04-01
US20100081801A1
Chemistry; metallurgy

Method for determining an unknown PNA sequence and uses thereof

#17 | 2010-01-21
US20100015122A1
Human necessities

Cloning of honey bee allergen

#18 | 2008-12-25
US20080317669A1
Chemistry; metallurgy

Cloning of honey bee allergen C

#19 | 2007-06-21
US20070141049A1
Chemistry; metallurgy

Bivalent IgY antibody constructs for diagnostic and therapeutic applications

#20 | 2006-06-15
US20060127394A1
Human necessities

Cloning of honey bee allergen

InventorID:

576420 ⎘